Author:
Sun Xiaodong,Yu Yerong,Han Lina
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Dey A, Williams RS, Pollock DM, Stepp DW, Newman JW, Hammock BD et al (2004) Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes Res 12(8):1278–1289
2. Kawar B, Bello AK, El NAM (2009) High prevalence of microalbuminuria in the overweight and obese population: data from a UK population screening programme. Nephron Clin Pract 112(3):c205–c212
3. Klausen KP, Parving HH, Scharling H, Jensen JS (2009) Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 71(1):40–45
4. Tebbe U, Bramlage P, Thoenes M, Paar WD, Danchin N, Volpe M et al (2009) Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. Swiss Med Wkly 139(33–34):473–480
5. Kalaitzidis RG, Siamopoulos KC (2011) The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol 43(3):771–784
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献